Search Within

Yuhong She

Formats
  1. Journal Article (16)
  2. Meeting Abstract (15)
Groups
  1. Department of Medicine (20)
  2. GSK Faculty (15)
  3. Sloan Kettering Institute Faculty (15)
  4. Solid Tumor Oncology Division (14)
  5. Molecular Pharmacology and Chemistry Program Faculty (13)
  6. Genitourinary Oncology Service (12)

More Groups

People
  1. Francis Sirotnak (19)
  2. Howard Scher (8)
  3. David Solit (7)
  4. Neal Rosen (7)
  5. Gary Schwartz (6)
  6. Fei Lee (5)

More People

Years
  1. 2009 (1)
  2. 2007 (1)
  3. 2006 (5)
  4. 2005 (6)
  5. 2004 (3)
  6. 2003 (7)

More Years

Publications
  1. Clinical Cancer Research (9)
  2. Cancer Research (4)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (4)
  4. Annals of Surgical Oncology (1)
  5. Blood (1)
  6. EJC Supplements (1)

More Publications

Publishers
  1. American Association for Cancer Research (18)
  2. Elsevier Science, Inc. (2)
  3. Nature Publishing Group (2)
  4. American Chemical Society (1)
  5. American Society for Clinical Investigation (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index
    Journal Article

    She, Y.; Lee, F.; Chen, J.; Haimovitz-Friedman, A.; Miller, V. A.; Rusch, V.; Kris, M. G.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Flavopiridol enhances the effect of docetaxel in Vitro and in Vivo in human gastric cancer cells
    Journal Article

    Motwani, M.; Rizzo, C.; Sirotnak, F.; She, Y.; Schwartz, G. K.
    Molecular Cancer Therapeutics (2003)

    Fulltext@MSK | Save
  • The cyclin-dependent kinase inhibitor flavopiridol potentiates γ-irradiation-induced apoptosis in colon and gastric cancer cells
    Journal Article

    Jung, C.; Motwani, M.; Kortmansky, J.; Sirotnak, F. M.; She, Y.; Gonen, M.; Haimovitz-Friedman, A.; Schwartz, G. K.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Alterations in MRP gene expression during step-wise progression of a human prostate tumor model to hormonal independence
    Meeting Abstract

    Sirotnak, F. M.; Lee, F.; Chen, J.; She, Y.; Scher, H. I.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • The selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') enhances radiation sensitivity of human tumor xenografts in nude mice
    Meeting Abstract

    She, Y.; Lee, F.; Haimovitz-Friedman, A.; Miller, V. A.; Rusch, V. W.; Kris, M. G.; Sirotnak, F. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
    Journal Article

    Sirotnak, F. M.; She, Y.; Lee, F.; Chen, J.; Scher, H. I.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells
    Journal Article

    Motwani, M.; Sirotnak, F. M.; She, Y.; Commes, T.; Schwartz, G. K.
    Cancer Research (2002)

    Fulltext@MSK | Save
  • Studies with CWR22 xenograft models in nude mice suggest that ZD1839 (Iressa) may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer
    Meeting Abstract

    Sirotnak, F. M.; She, Y.; Lee, F.; Scher, H. I.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • PDX, a novel antifolate with potent in vitro and in vivo activity in non-Hodgkin's lymphoma
    Meeting Abstract

    Wang, E. S.; O'connor, O.; Zhang, K.; She, Y.; Zelenetz, A.; Sirotnak, F. M.; Moore, M. A. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts
    Journal Article

    Motwani, M.; Jung, C.; Sirotnak, F. M.; She, Y.; Shah, M. A.; Gonen, M.; Schwartz, G. K.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save